189 related articles for article (PubMed ID: 38372151)
21. The Growing Importance of Three-Dimensional Models and Microphysiological Systems in the Assessment of Mycotoxin Toxicity.
Zingales V; Esposito MR; Torriero N; Taroncher M; Cimetta E; Ruiz MJ
Toxins (Basel); 2023 Jun; 15(7):. PubMed ID: 37505691
[TBL] [Abstract][Full Text] [Related]
22. From organ-on-chip to body-on-chip: The next generation of microfluidics platforms for in vitro drug efficacy and toxicity testing.
Lacombe J; Soldevila M; Zenhausern F
Prog Mol Biol Transl Sci; 2022; 187(1):41-91. PubMed ID: 35094781
[TBL] [Abstract][Full Text] [Related]
23. Biosensors integrated 3D organoid/organ-on-a-chip system: A real-time biomechanical, biophysical, and biochemical monitoring and characterization.
Liu S; Kumari S; He H; Mishra P; Singh BN; Singh D; Liu S; Srivastava P; Li C
Biosens Bioelectron; 2023 Jul; 231():115285. PubMed ID: 37058958
[TBL] [Abstract][Full Text] [Related]
24. The Application of Organs-on-a-Chip in Dental, Oral, and Craniofacial Research.
Huang C; Sanaei F; Verdurmen WPR; Yang F; Ji W; Walboomers XF
J Dent Res; 2023 Apr; 102(4):364-375. PubMed ID: 36726271
[TBL] [Abstract][Full Text] [Related]
25. Human organ chips for regenerative pharmacology.
Goyal G; Belgur C; Ingber DE
Pharmacol Res Perspect; 2024 Feb; 12(1):e01159. PubMed ID: 38149766
[TBL] [Abstract][Full Text] [Related]
26. Organs-on-a-Chip.
Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
[TBL] [Abstract][Full Text] [Related]
27. Multiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges.
Wang YI; Carmona C; Hickman JJ; Shuler ML
Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29205920
[TBL] [Abstract][Full Text] [Related]
28. Advances in TEER measurements of biological barriers in microphysiological systems.
Nazari H; Shrestha J; Naei VY; Bazaz SR; Sabbagh M; Thiery JP; Warkiani ME
Biosens Bioelectron; 2023 Aug; 234():115355. PubMed ID: 37159988
[TBL] [Abstract][Full Text] [Related]
29. Standalone cell culture microfluidic device-based microphysiological system for automated cell observation and application in nephrotoxicity tests.
Kimura H; Nakamura H; Goto T; Uchida W; Uozumi T; Nishizawa D; Shinha K; Sakagami J; Doi K
Lab Chip; 2024 Jan; 24(3):408-421. PubMed ID: 38131210
[TBL] [Abstract][Full Text] [Related]
30. Cross-industrial applications of organotypic models.
Kopanska KS; Rimann M
ALTEX; 2022; 39(1):155-158. PubMed ID: 35034134
[TBL] [Abstract][Full Text] [Related]
31. Cultivating human tissues and organs over lab-on-a-chip models: Recent progress and applications.
Bhagat S; Singh S
Prog Mol Biol Transl Sci; 2022; 187(1):205-240. PubMed ID: 35094775
[TBL] [Abstract][Full Text] [Related]
32. Tailoring biomaterials for biomimetic organs-on-chips.
Sun L; Bian F; Xu D; Luo Y; Wang Y; Zhao Y
Mater Horiz; 2023 Oct; 10(11):4724-4745. PubMed ID: 37697735
[TBL] [Abstract][Full Text] [Related]
33. Academic User View: Organ-on-a-Chip Technology.
Busek M; Aizenshtadt A; Amirola-Martinez M; Delon L; Krauss S
Biosensors (Basel); 2022 Feb; 12(2):. PubMed ID: 35200386
[TBL] [Abstract][Full Text] [Related]
34. Bioethical implications of organ-on-a-chip on modernizing drug development.
Thakar RG; Fenton KN
Artif Organs; 2023 Oct; 47(10):1553-1558. PubMed ID: 37578206
[TBL] [Abstract][Full Text] [Related]
35. Proceedings of the First Workshop on Standards for Microfluidics.
Reyes DR; van Heeren H
J Res Natl Inst Stand Technol; 2019; 124():1-22. PubMed ID: 34877172
[TBL] [Abstract][Full Text] [Related]
36. Organ/body-on-a-chip based on microfluidic technology for drug discovery.
Kimura H; Sakai Y; Fujii T
Drug Metab Pharmacokinet; 2018 Feb; 33(1):43-48. PubMed ID: 29175062
[TBL] [Abstract][Full Text] [Related]
37. New horizons of microphysiological systems: India forging its path in human-relevant research.
Parvatam S; Mahadik K; Banerjee A; Patil K; Radha V; Rao M
Biol Open; 2023 Apr; 12(4):. PubMed ID: 37070566
[TBL] [Abstract][Full Text] [Related]
38. Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges.
Irrechukwu O; Yeager R; David R; Ekert J; Saravanakumar A; Choi CK
ALTEX; 2023; 40(3):485-518. PubMed ID: 36648096
[TBL] [Abstract][Full Text] [Related]
39. Increasingly microphysiological models.
Nat Biomed Eng; 2019 Jul; 3(7):491-492. PubMed ID: 31278390
[No Abstract] [Full Text] [Related]
40. Recent progress of organ-on-a-chip towards cardiovascular diseases: advanced design, fabrication, and applications.
Wu H; Shi S; Liu Y; Zhang Q; Lam RHW; Lim CT; Hu J
Biofabrication; 2023 Jul; 15(4):. PubMed ID: 37267929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
